|Bid||8.74 x 3000|
|Ask||8.97 x 2900|
|Day's Range||8.68 - 9.00|
|52 Week Range||8.60 - 19.43|
|Beta (5Y Monthly)||1.65|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 02, 2021 - Nov 08, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||20.67|
A look at the shareholders of Sangamo Therapeutics, Inc. ( NASDAQ:SGMO ) can tell us which group is most powerful...
BRISBANE, Calif., August 31, 2021--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will be participating in fireside chats at the following investor conferences:
We can readily understand why investors are attracted to unprofitable companies. For example, although...